- Science & Research
- Science News
- Newsletter
- 2005
- September 17
Newsletter
Newsletter
Defect in tumor suppressor gene leaves prostate cells susceptible to oxidative damage and cancer
September 17, 2005 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
Life Extension Update Exclusive Defect in tumor suppressor gene leaves prostate cells susceptible to oxidative damage and cancer Researchers from Johns Hopkins Kimmel Cancer Center in Maryland and the Cancer Institute of New Jersey found that the malfunction of a gene known as Nkx3.1 causes a loss of prostate cells’ protection against damage by oxygen. Oxygen can damage cells by triggering the formation of free radicals, highly reactive molecules that damage cells, which can lead to cancer and other diseases. Previous research had revealed that Nkx3.1 is required for prostatic epithelial differentiation and suppression of prostate cancer. Although the research in the current study involved mice, the same genetic pathway is involved in human prostate cancer. The finding was published in the August 1 2005 issue of the journal Cancer Research (http://cancerres.aacrjournals.org). The research team found that Nkx3.1 prevents oxidative damage by regulating the expression of other genes. Mice whose Nkx3.1 gene was disrupted were found to incorrectly express 638 genes, some of which caused a reduction in antioxidant enzymes such as glutathione peroxidase 2 and 3 that prevent oxidative damage from occurring. These changes were observed in mice as young as four months of age. Additionally, the mice experienced five times the amount of cancer-causing DNA damage than that which would occur in normal mice. Study coauthor Theodore L. DeWeese, MD, who is the director of the Department of Radiation Oncology & Molecular Radiation Sciences at Johns Hopkins explained, "Normally, cells with functioning Nkx3.1 seem to process oxidative free radicals appropriately. But cells with faulty Nkx3.1 genes cannot manage oxidative injury. Then, their DNA gets damaged, and that leads to other mutations that in turn can bring about cancer." Lead author Corby Abate-Shen, PhD, of the University of Medicine and Dentistry of New Jersey-Center for Advanced Biotechnology and Medicine, added, "Our findings provide new insights regarding the relationship between loss of protection against oxidative stress and the initiation of prostate cancer . . . Mice with defective Nkx3.1 provide a valuable tool for preclinical studies to test whether antioxidants might be useful for prostate cancer prevention." | ||||||||||||||||||||||||||||||
Protocol Of all nutritional literature currently in existence relating to PC (prostate cancer), the relationship between lycopene ingestion and the health of the prostate is the clearest. Lycopene consumption been found to decrease not only the risk of PC in multiple studies, but also the risk of BC17 and pancreatic and stomach cancer, as well as lung cancer. Measures to prevent PC must be a routine part of the counsel that general practitioners and internists give their patients. Selenium intake of at least 200 mcg a day should be a consideration in the prevention of PC. Low plasma selenium is associated with a four- to fivefold increased risk of PC. In addition, levels of plasma selenium also decrease with age, resulting in middle-aged to older men being at a higher risk for low selenium levels. Ideally, baseline levels of selenium should be obtained before beginning routine selenium supplementation. It would make sense to begin such a micronutrient and mineral assessment at age 25 and perhaps every 10 years thereafter. Research studies have shown that vitamin E reduces growth rates of PCs resulting from a high fat diet. Tumor growth rates were highest in the animals fed a 40.5%-kcal fat diet (the typical American diet). Tumors in animals fed 40.5%-kcal fat plus vitamin E were the same as those fed a 21.2%- kcal fat diet (an ideal fat level). Combining one LE Booster softgel with one LE Vitamin E capsule containing 400 IU of D-alpha-tocopherol succinate, in conjunction with the dietary approaches detailed in previous paragraphs, should contribute significantly to both the prevention and active nutritional treatment of PC. | ||||||||||||||||||||||||||||||
Featured Products
| ||||||||||||||||||||||||||||||
Take advantage of the Life Extension Platinum Plus® Master Card® and help fund research As a Life Extension customer, you are committed to our ongoing search to uncover integrative therapies which prevent and treat many diseases associated with aging as well as aging itself. Now, by simply using your Life Extension MasterCard credit card to make your regular credit card purchases, you can effectively contribute to our cause. Use your Life Extension MasterCard credit card, and a percentage of your purchase price will be sent to Life Extension to help us fund the antiaging studies that we use to develop our products and services. | ||||||||||||||||||||||||||||||
Questions? Comments? Send them to ddye@lifeextension.com or call 1-800-678-8989. For longer life, Dayna Dye Sign up for Life Extension Update at https://mycart.lifeextension.com/subscribe.asp Help spread the good news about living longer and healthier. Forward this email to a friend! View previous issues of Life Extension Update in the Newsletter Archive. |
Lab
Testing
How Life Extension lab testing works